These results confirm and extend our previous findings suggesting that loss of vascular smooth muscle GLUT4 expression leads to abnormal vasoreactivty in hypertension and implicate complex mechanisms by which maintenance of vascular smooth muscle GLUT4 expression can normalize defects in endothelium-dependent vasorelaxation. The gene discussed is SLC2A4; the disease is hypertensive disorder.